<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03945942</url>
  </required_header>
  <id_info>
    <org_study_id>2018/07NOV/413</org_study_id>
    <nct_id>NCT03945942</nct_id>
  </id_info>
  <brief_title>Influence of Hyperbilirubinaemia on Two Different Near Infrared Spectroscopy Devices</brief_title>
  <acronym>NIRS_GREFFE</acronym>
  <official_title>Influence of Hyperbilirubinaemia on Foresight and INVOS Oximetry Values in Pediatric Hepatic Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Protocol Near infrared spectroscopy liver transplants: comparison of two monitoring of Near&#xD;
      infrared spectroscopy in pediatric liver transplant.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hyperbilirubinaemia may interfere with oximetry values as measured by Near Infrared&#xD;
      Spectroscopy devices. The number of wave lengths used by different devices can influence the&#xD;
      oximetry values in adult patients. This has never been demonstrated in children with&#xD;
      hyperbilirubinaemia scheduled for elective liver transplantation.The study will compare&#xD;
      cerebral and somatic oximetry values measured by two different Near infrared spectroscopy&#xD;
      devices (FORESIGHT and INVOS) and analyse the influence of bilirubin levels on these&#xD;
      differences.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 15, 2019</start_date>
  <completion_date type="Actual">October 15, 2020</completion_date>
  <primary_completion_date type="Actual">October 15, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>influence of chromophores such as bilirubin on oximetry values provided by two different devices</measure>
    <time_frame>From Day 0 of surgery until arrival at pediatric intensive care unit (up to 12 hours)</time_frame>
    <description>measure of oximetry values by two different devices at different time points in function of serum bilirubin levels</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">33</enrollment>
  <condition>Liver Transplant; Complications</condition>
  <arm_group>
    <arm_group_label>Pediatric liver transplant patients</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Using somatic and cerebral Near infrared spectroscopy devices</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Near infrared spectroscopy with INVOS device</intervention_name>
    <description>somatic and cerebral oximetry by INVOS in pediatric liver transplantation</description>
    <arm_group_label>Pediatric liver transplant patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Near infrared spectroscopy with Foresight device</intervention_name>
    <description>somatic and cerebral oximetry with Foresight device in pediatric liver transplantation</description>
    <arm_group_label>Pediatric liver transplant patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Pediatric patients 0 to 18 years, with a liver transplant with living donor program of&#xD;
             our institution&#xD;
&#xD;
          -  Free, informed and written consent signed by the investigator or employees and by the&#xD;
             legal guardians of minor patients in the days preceding the procedure&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  refusal of the patient or his parents to consent&#xD;
&#xD;
          -  known brain or Neurological pathology&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Natalia MAGASICH-AIROLA, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>natalia.magasich@uclouvain.be</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cliniques Universitaires Saint-Luc</name>
      <address>
        <city>Brussels</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 4, 2019</study_first_submitted>
  <study_first_submitted_qc>May 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 10, 2019</study_first_posted>
  <last_update_submitted>March 17, 2021</last_update_submitted>
  <last_update_submitted_qc>March 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperbilirubinemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

